Document is current

Any future updates will be listed below

Correction: Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma

Crossref DOI link: https://doi.org/10.1007/s00432-025-06103-2

Published Online: 2025-03-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark